Boron-Doped LiCoPO4 as a High-Voltage Cathode for Lithium-Ion Batteries
Горение и плазмохимия · 06.04.2026 · 24 (1) · 1-7
DOI: 10.18321/cpc24(1)1-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Горение и плазмохимия, online erschienen am 06.04.2026. Verfasst von A. Abilkhan und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The primary aim of this work is to demonstrate the influence of boron doping on LiCoPO4 (LCP) cathodes with a focus on conductivity and interfacial processes. Pristine and B-doped LCP were synthesized via a two-step solid-state method. XRD and SEM confirmed phase purity, lattice distortion and reduced particle size in the doped sample. Electrochemical impedance spectroscopy showed improved lithium-ion diffusion, higher coulombic efficiency (to ~75% vs. ~65%) and moderate capacity retention for the doped sample (~60 mAh·g-1 after 20 cycles) compared to pristine LCP. These findings highlight that boron doping effectively enhances conductivity and mitigates interfacial limitations of LCP, providing a promising, but still preliminary strategy for the development of high-voltage LIBs cathodes.
Zitieren
APA
Abilkhan, A., Volobuyeva, V., Tugelbay, S., Batyrbekuly, D., Sultanov, F., Umirov, N., & Tatykayev, B. (2026). Boron-Doped LiCoPO4 as a High-Voltage Cathode for Lithium-Ion Batteries. Горение и плазмохимия, 24(1), 1-7. https://doi.org/10.18321/cpc24(1)1-7
Vancouver
Abilkhan A, Volobuyeva V, Tugelbay S, Batyrbekuly D, Sultanov F, Umirov N, et al. Boron-Doped LiCoPO4 as a High-Voltage Cathode for Lithium-Ion Batteries. Горение и плазмохимия. 2026;24(1):1-7. doi:10.18321/cpc24(1)1-7
BibTeX
@article{Abilkhan2026,
author = {Abilkhan, A. and Volobuyeva, V. and Tugelbay, S. and Batyrbekuly, D. and Sultanov, F. and Umirov, N. and Tatykayev, B.},
title = {Boron-Doped LiCoPO4 as a High-Voltage Cathode for Lithium-Ion Batteries},
journal = {Горение и плазмохимия},
year = {2026},
volume = {24},
number = {1},
pages = {1--7},
doi = {10.18321/cpc24(1)1-7}
}
EUVIMED